Savara (SVRA) PT Lowered to $2 at Evercore ISI

Evercore ISI analyst Liisa Bayko lowered the price target on Savara (NASDAQ: SVRA) to $2.00 (from $3.00) while maintaining a In Line rating.

The analyst comments "As we expected, CMC plagued SVRA’s BLA for Molbreevi in aPAP, prompting a 30% reset in valuation. We expect SVRA could be ready to refile the BLA in 4Q, triggering a 3Q26 PDUFA, assuming priority review. We have pushed out launch expectations to January 2027, while maintaining our 60% probability of approval pending additional details on RTF and tech transfer. As such, our price target goes to $2."

You May Also Be Interested In

• York Space Systems (YSS) PT Lowered to $15 at Jefferies
• BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
• Brookfield offers A$4.75/sh for Reliance Worldwide - Bloomberg